Tag:

Glumetza

Latest Headlines

Latest Headlines

Janssen gets Acuform tech rights

August 6, 2010
Johnson & Johnson ( NYSE: JNJ ) unit Janssen Pharmaceutica has licensed worldwide rights to Depomed's ( NASDAQ: DEPO ) Acuform gastric retentive drug delivery technology. Depomed will receive a $5

Related Tags

Press Releases

Featured Jobs